Industry Research Reports

Home > Reports > Medical Care > Global Kidney Cancer Therapeutics Market Insights, Forecast to 2030

Global Kidney Cancer Therapeutics Market Insights, Forecast to 2030

Industry: Medical Care

Published Date: 2024-04-15

Pages: 111 Pages

Report ld: 2846282

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Kidney Cancer Therapeutics Market Size(US$)

CAGR 2024-2030

3.8%

Market Size,2030

USD 547

Million

Market Snapshot

Market Size in 2024 (Value)

US$ 437.4 million

Market Forecast in 2030(Value)

US$ 547 million

CAGR

3.8%

Years Considered

2019-2030

Base Year

2024

Forecast Period

2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

Kidney cancer is cancer that begins in the kidneys. Your kidneys are two bean-shaped organs, each about the size of your fist. They're located behind your abdominal organs, with one kidney on each side of your spine. In adults, renal cell carcinoma is the most common type of kidney cancer.

Market Analysis and Insights: Global Kidney Cancer Therapeutics Market

The global Kidney Cancer Therapeutics market is projected to grow from US$ 437.4 million in 2024 to US$ 547 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.8% during the forecast period.

The kidney cancer therapeutics market is evolving rapidly to address the treatment needs of patients diagnosed with kidney cancer, also known as renal cell carcinoma (RCC). This market encompasses a range of therapies, including targeted therapies, immunotherapies, and combination treatments. The increasing incidence of kidney cancer, advancements in understanding its molecular basis, and the emergence of novel treatment options are driving market growth. Targeted therapies that inhibit specific pathways implicated in kidney cancer progression, along with immunotherapies that harness the immune system's response, are gaining prominence. As research continues and personalized treatment approaches gain traction, the kidney cancer therapeutics market is expected to expand, offering new hope for improved outcomes and quality of life for patients with this challenging disease.

Report Covers:

This report presents an overview of global market for Kidney Cancer Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Kidney Cancer Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Kidney Cancer Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Kidney Cancer Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Kidney Cancer Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Kidney Cancer Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

MARKET SEGMENTATION

By Company

Merck
Novartis
Bristol-Myers Squibb
Pfizer
Roche
Amgen
Aveo Pharmaceuticals
Bayer
Exelixis
Eisai

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Surgery
Immunotherapy
Targeted Therapy
Other

Segment by Application

Renal Cell Carcinoma
Renal Pelvis Cancer
Other

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Kidney Cancer Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Surgery

1.2.3 Immunotherapy

1.2.4 Targeted Therapy

1.2.5 Other

1.3 Market by Application

1.3.1 Global Kidney Cancer Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Renal Cell Carcinoma

1.3.3 Renal Pelvis Cancer

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Kidney Cancer Therapeutics Market Perspective (2019-2030)

2.2 Global Kidney Cancer Therapeutics Growth Trends by Region

2.2.1 Kidney Cancer Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Kidney Cancer Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Kidney Cancer Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Kidney Cancer Therapeutics Market Dynamics

2.3.1 Kidney Cancer Therapeutics Industry Trends

2.3.2 Kidney Cancer Therapeutics Market Drivers

2.3.3 Kidney Cancer Therapeutics Market Challenges

2.3.4 Kidney Cancer Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Kidney Cancer Therapeutics by Players

3.1.1 Global Kidney Cancer Therapeutics Revenue by Players (2019-2024)

3.1.2 Global Kidney Cancer Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Kidney Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Kidney Cancer Therapeutics, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Kidney Cancer Therapeutics Market Concentration Ratio

3.4.1 Global Kidney Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Kidney Cancer Therapeutics Revenue in 2023

3.5 Global Key Players of Kidney Cancer Therapeutics Head office and Area Served

3.6 Global Key Players of Kidney Cancer Therapeutics, Product and Application

3.7 Global Key Players of Kidney Cancer Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Kidney Cancer Therapeutics Breakdown Data by Type

4.1 Global Kidney Cancer Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Kidney Cancer Therapeutics Forecasted Market Size by Type (2025-2030)

5 Kidney Cancer Therapeutics Breakdown Data by Application

5.1 Global Kidney Cancer Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Kidney Cancer Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Kidney Cancer Therapeutics Market Size (2019-2030)

6.2 North America Kidney Cancer Therapeutics Market Size by Type

6.2.1 North America Kidney Cancer Therapeutics Market Size by Type (2019-2024)

6.2.2 North America Kidney Cancer Therapeutics Market Size by Type (2025-2030)

6.2.3 North America Kidney Cancer Therapeutics Market Share by Type (2019-2030)

6.3 North America Kidney Cancer Therapeutics Market Size by Application

6.3.1 North America Kidney Cancer Therapeutics Market Size by Application (2019-2024)

6.3.2 North America Kidney Cancer Therapeutics Market Size by Application (2025-2030)

6.3.3 North America Kidney Cancer Therapeutics Market Share by Application (2019-2030)

6.4 North America Kidney Cancer Therapeutics Market Size by Country

6.4.1 North America Kidney Cancer Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Kidney Cancer Therapeutics Market Size by Country (2019-2024)

6.4.3 North America Kidney Cancer Therapeutics Market Size by Country (2025-2030)

6.4.4 United States

6.4.5 Canada

7 Europe

7.1 Europe Kidney Cancer Therapeutics Market Size (2019-2030)

7.2 Europe Kidney Cancer Therapeutics Market Size by Type

7.2.1 Europe Kidney Cancer Therapeutics Market Size by Type (2019-2024)

7.2.2 Europe Kidney Cancer Therapeutics Market Size by Type (2025-2030)

7.2.3 Europe Kidney Cancer Therapeutics Market Share by Type (2019-2030)

7.3 Europe Kidney Cancer Therapeutics Market Size by Application

7.3.1 Europe Kidney Cancer Therapeutics Market Size by Application (2019-2024)

7.3.2 Europe Kidney Cancer Therapeutics Market Size by Application (2025-2030)

7.3.3 Europe Kidney Cancer Therapeutics Market Share by Application (2019-2030)

7.4 Europe Kidney Cancer Therapeutics Market Size by Country

7.4.1 Europe Kidney Cancer Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Kidney Cancer Therapeutics Market Size by Country (2019-2024)

7.4.3 Europe Kidney Cancer Therapeutics Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Kidney Cancer Therapeutics Market Size (2019-2030)

8.2 China Kidney Cancer Therapeutics Market Size by Type

8.2.1 China Kidney Cancer Therapeutics Market Size by Type (2019-2024)

8.2.2 China Kidney Cancer Therapeutics Market Size by Type (2025-2030)

8.2.3 China Kidney Cancer Therapeutics Market Share by Type (2019-2030)

8.3 China Kidney Cancer Therapeutics Market Size by Application

8.3.1 China Kidney Cancer Therapeutics Market Size by Application (2019-2024)

8.3.2 China Kidney Cancer Therapeutics Market Size by Application (2025-2030)

8.3.3 China Kidney Cancer Therapeutics Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Kidney Cancer Therapeutics Market Size (2019-2030)

9.2 Asia Kidney Cancer Therapeutics Market Size by Type

9.2.1 Asia Kidney Cancer Therapeutics Market Size by Type (2019-2024)

9.2.2 Asia Kidney Cancer Therapeutics Market Size by Type (2025-2030)

9.2.3 Asia Kidney Cancer Therapeutics Market Share by Type (2019-2030)

9.3 Asia Kidney Cancer Therapeutics Market Size by Application

9.3.1 Asia Kidney Cancer Therapeutics Market Size by Application (2019-2024)

9.3.2 Asia Kidney Cancer Therapeutics Market Size by Application (2025-2030)

9.3.3 Asia Kidney Cancer Therapeutics Market Share by Application (2019-2030)

9.4 Asia Kidney Cancer Therapeutics Market Size by Region

9.4.1 Asia Kidney Cancer Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Kidney Cancer Therapeutics Market Size by Region (2019-2024)

9.4.3 Asia Kidney Cancer Therapeutics Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Kidney Cancer Therapeutics Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Kidney Cancer Therapeutics Market Size by Type

10.2.1 Middle East, Africa, and Latin America Kidney Cancer Therapeutics Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Kidney Cancer Therapeutics Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Kidney Cancer Therapeutics Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Kidney Cancer Therapeutics Market Size by Application

10.3.1 Middle East, Africa, and Latin America Kidney Cancer Therapeutics Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Kidney Cancer Therapeutics Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Kidney Cancer Therapeutics Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Kidney Cancer Therapeutics Market Size by Country

10.4.1 Middle East, Africa, and Latin America Kidney Cancer Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Kidney Cancer Therapeutics Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Kidney Cancer Therapeutics Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Merck

11.1.1 Merck Company Details

11.1.2 Merck Business Overview

11.1.3 Merck Kidney Cancer Therapeutics Introduction

11.1.4 Merck Revenue in Kidney Cancer Therapeutics Business (2019-2024)

11.1.5 Merck Recent Developments

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Kidney Cancer Therapeutics Introduction

11.2.4 Novartis Revenue in Kidney Cancer Therapeutics Business (2019-2024)

11.2.5 Novartis Recent Developments

11.3 Bristol-Myers Squibb

11.3.1 Bristol-Myers Squibb Company Details

11.3.2 Bristol-Myers Squibb Business Overview

11.3.3 Bristol-Myers Squibb Kidney Cancer Therapeutics Introduction

11.3.4 Bristol-Myers Squibb Revenue in Kidney Cancer Therapeutics Business (2019-2024)

11.3.5 Bristol-Myers Squibb Recent Developments

11.4 Pfizer

11.4.1 Pfizer Company Details

11.4.2 Pfizer Business Overview

11.4.3 Pfizer Kidney Cancer Therapeutics Introduction

11.4.4 Pfizer Revenue in Kidney Cancer Therapeutics Business (2019-2024)

11.4.5 Pfizer Recent Developments

11.5 Roche

11.5.1 Roche Company Details

11.5.2 Roche Business Overview

11.5.3 Roche Kidney Cancer Therapeutics Introduction

11.5.4 Roche Revenue in Kidney Cancer Therapeutics Business (2019-2024)

11.5.5 Roche Recent Developments

11.6 Amgen

11.6.1 Amgen Company Details

11.6.2 Amgen Business Overview

11.6.3 Amgen Kidney Cancer Therapeutics Introduction

11.6.4 Amgen Revenue in Kidney Cancer Therapeutics Business (2019-2024)

11.6.5 Amgen Recent Developments

11.7 Aveo Pharmaceuticals

11.7.1 Aveo Pharmaceuticals Company Details

11.7.2 Aveo Pharmaceuticals Business Overview

11.7.3 Aveo Pharmaceuticals Kidney Cancer Therapeutics Introduction

11.7.4 Aveo Pharmaceuticals Revenue in Kidney Cancer Therapeutics Business (2019-2024)

11.7.5 Aveo Pharmaceuticals Recent Developments

11.8 Bayer

11.8.1 Bayer Company Details

11.8.2 Bayer Business Overview

11.8.3 Bayer Kidney Cancer Therapeutics Introduction

11.8.4 Bayer Revenue in Kidney Cancer Therapeutics Business (2019-2024)

11.8.5 Bayer Recent Developments

11.9 Exelixis

11.9.1 Exelixis Company Details

11.9.2 Exelixis Business Overview

11.9.3 Exelixis Kidney Cancer Therapeutics Introduction

11.9.4 Exelixis Revenue in Kidney Cancer Therapeutics Business (2019-2024)

11.9.5 Exelixis Recent Developments

11.10 Eisai

11.10.1 Eisai Company Details

11.10.2 Eisai Business Overview

11.10.3 Eisai Kidney Cancer Therapeutics Introduction

11.10.4 Eisai Revenue in Kidney Cancer Therapeutics Business (2019-2024)

11.10.5 Eisai Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

TABLE OF FIGURES

List of Tables

Table 1. Global Kidney Cancer Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Surgery

Table 3. Key Players of Immunotherapy

Table 4. Key Players of Targeted Therapy

Table 5. Key Players of Other

Table 6. Global Kidney Cancer Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 7. Global Kidney Cancer Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Kidney Cancer Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Kidney Cancer Therapeutics Market Share by Region (2019-2024)

Table 10. Global Kidney Cancer Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Kidney Cancer Therapeutics Market Share by Region (2025-2030)

Table 12. Kidney Cancer Therapeutics Market Trends

Table 13. Kidney Cancer Therapeutics Market Drivers

Table 14. Kidney Cancer Therapeutics Market Challenges

Table 15. Kidney Cancer Therapeutics Market Restraints

Table 16. Global Kidney Cancer Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Kidney Cancer Therapeutics Revenue Share by Players (2019-2024)

Table 18. Global Top Kidney Cancer Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer Therapeutics as of 2023)

Table 19. Global Kidney Cancer Therapeutics Industry Ranking 2022 VS 2023 VS 2024

Table 20. Global 5 Largest Players Market Share by Kidney Cancer Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Kidney Cancer Therapeutics, Headquarters and Area Served

Table 22. Global Key Players of Kidney Cancer Therapeutics, Product and Application

Table 23. Global Key Players of Kidney Cancer Therapeutics, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Kidney Cancer Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Kidney Cancer Therapeutics Revenue Market Share by Type (2019-2024)

Table 27. Global Kidney Cancer Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Kidney Cancer Therapeutics Revenue Market Share by Type (2025-2030)

Table 29. Global Kidney Cancer Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Kidney Cancer Therapeutics Revenue Share by Application (2019-2024)

Table 31. Global Kidney Cancer Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Kidney Cancer Therapeutics Revenue Share by Application (2025-2030)

Table 33. North America Kidney Cancer Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Kidney Cancer Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Kidney Cancer Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Kidney Cancer Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Kidney Cancer Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Kidney Cancer Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Kidney Cancer Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Kidney Cancer Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Kidney Cancer Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Kidney Cancer Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Kidney Cancer Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Kidney Cancer Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Kidney Cancer Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Kidney Cancer Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Kidney Cancer Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Kidney Cancer Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Kidney Cancer Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Kidney Cancer Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Kidney Cancer Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Kidney Cancer Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Kidney Cancer Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Kidney Cancer Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Kidney Cancer Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Kidney Cancer Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Kidney Cancer Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Kidney Cancer Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Kidney Cancer Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Kidney Cancer Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Kidney Cancer Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Kidney Cancer Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Kidney Cancer Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Kidney Cancer Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 65. Merck Company Details

Table 66. Merck Business Overview

Table 67. Merck Kidney Cancer Therapeutics Product

Table 68. Merck Revenue in Kidney Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 69. Merck Recent Developments

Table 70. Novartis Company Details

Table 71. Novartis Business Overview

Table 72. Novartis Kidney Cancer Therapeutics Product

Table 73. Novartis Revenue in Kidney Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 74. Novartis Recent Developments

Table 75. Bristol-Myers Squibb Company Details

Table 76. Bristol-Myers Squibb Business Overview

Table 77. Bristol-Myers Squibb Kidney Cancer Therapeutics Product

Table 78. Bristol-Myers Squibb Revenue in Kidney Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 79. Bristol-Myers Squibb Recent Developments

Table 80. Pfizer Company Details

Table 81. Pfizer Business Overview

Table 82. Pfizer Kidney Cancer Therapeutics Product

Table 83. Pfizer Revenue in Kidney Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 84. Pfizer Recent Developments

Table 85. Roche Company Details

Table 86. Roche Business Overview

Table 87. Roche Kidney Cancer Therapeutics Product

Table 88. Roche Revenue in Kidney Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 89. Roche Recent Developments

Table 90. Amgen Company Details

Table 91. Amgen Business Overview

Table 92. Amgen Kidney Cancer Therapeutics Product

Table 93. Amgen Revenue in Kidney Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 94. Amgen Recent Developments

Table 95. Aveo Pharmaceuticals Company Details

Table 96. Aveo Pharmaceuticals Business Overview

Table 97. Aveo Pharmaceuticals Kidney Cancer Therapeutics Product

Table 98. Aveo Pharmaceuticals Revenue in Kidney Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 99. Aveo Pharmaceuticals Recent Developments

Table 100. Bayer Company Details

Table 101. Bayer Business Overview

Table 102. Bayer Kidney Cancer Therapeutics Product

Table 103. Bayer Revenue in Kidney Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 104. Bayer Recent Developments

Table 105. Exelixis Company Details

Table 106. Exelixis Business Overview

Table 107. Exelixis Kidney Cancer Therapeutics Product

Table 108. Exelixis Revenue in Kidney Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 109. Exelixis Recent Developments

Table 110. Eisai Company Details

Table 111. Eisai Business Overview

Table 112. Eisai Kidney Cancer Therapeutics Product

Table 113. Eisai Revenue in Kidney Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 114. Eisai Recent Developments

Table 115. Research Programs/Design for This Report

Table 116. Key Data Information from Secondary Sources

Table 117. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Kidney Cancer Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Kidney Cancer Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. Surgery Features

Figure 4. Immunotherapy Features

Figure 5. Targeted Therapy Features

Figure 6. Other Features

Figure 7. Global Kidney Cancer Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Kidney Cancer Therapeutics Market Share by Application: 2023 VS 2030

Figure 9. Renal Cell Carcinoma Case Studies

Figure 10. Renal Pelvis Cancer Case Studies

Figure 11. Other Case Studies

Figure 12. Kidney Cancer Therapeutics Report Years Considered

Figure 13. Global Kidney Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Kidney Cancer Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Kidney Cancer Therapeutics Market Share by Region: 2023 VS 2030

Figure 16. Global Kidney Cancer Therapeutics Market Share by Players in 2023

Figure 17. Global Top Kidney Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer Therapeutics as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Kidney Cancer Therapeutics Revenue in 2023

Figure 19. North America Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Kidney Cancer Therapeutics Market Share by Type (2019-2030)

Figure 21. North America Kidney Cancer Therapeutics Market Share by Application (2019-2030)

Figure 22. North America Kidney Cancer Therapeutics Market Share by Country (2019-2030)

Figure 23. United States Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Kidney Cancer Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 26. Europe Kidney Cancer Therapeutics Market Share by Type (2019-2030)

Figure 27. Europe Kidney Cancer Therapeutics Market Share by Application (2019-2030)

Figure 28. Europe Kidney Cancer Therapeutics Market Share by Country (2019-2030)

Figure 29. Germany Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Kidney Cancer Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 36. China Kidney Cancer Therapeutics Market Share by Type (2019-2030)

Figure 37. China Kidney Cancer Therapeutics Market Share by Application (2019-2030)

Figure 38. Asia Kidney Cancer Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 39. Asia Kidney Cancer Therapeutics Market Share by Type (2019-2030)

Figure 40. Asia Kidney Cancer Therapeutics Market Share by Application (2019-2030)

Figure 41. Asia Kidney Cancer Therapeutics Market Share by Region (2019-2030)

Figure 42. Japan Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. China Taiwan Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. India Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Australia Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Kidney Cancer Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Kidney Cancer Therapeutics Market Share by Type (2019-2030)

Figure 50. Middle East, Africa, and Latin America Kidney Cancer Therapeutics Market Share by Application (2019-2030)

Figure 51. Middle East, Africa, and Latin America Kidney Cancer Therapeutics Market Share by Country (2019-2030)

Figure 52. Brazil Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Mexico Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Turkey Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Israel Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. GCC Countries Kidney Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Merck Revenue Growth Rate in Kidney Cancer Therapeutics Business (2019-2024)

Figure 59. Novartis Revenue Growth Rate in Kidney Cancer Therapeutics Business (2019-2024)

Figure 60. Bristol-Myers Squibb Revenue Growth Rate in Kidney Cancer Therapeutics Business (2019-2024)

Figure 61. Pfizer Revenue Growth Rate in Kidney Cancer Therapeutics Business (2019-2024)

Figure 62. Roche Revenue Growth Rate in Kidney Cancer Therapeutics Business (2019-2024)

Figure 63. Amgen Revenue Growth Rate in Kidney Cancer Therapeutics Business (2019-2024)

Figure 64. Aveo Pharmaceuticals Revenue Growth Rate in Kidney Cancer Therapeutics Business (2019-2024)

Figure 65. Bayer Revenue Growth Rate in Kidney Cancer Therapeutics Business (2019-2024)

Figure 66. Exelixis Revenue Growth Rate in Kidney Cancer Therapeutics Business (2019-2024)

Figure 67. Eisai Revenue Growth Rate in Kidney Cancer Therapeutics Business (2019-2024)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which region is expected to have the highest market share? zhanKai

For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 3.8% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.

What was the global market size of Kidney Cancer Therapeutics in 2024? shouQi

Which companies rank high in the global Kidney Cancer Therapeutics market? shouQi

What is the annual compound growth rate of the global Kidney Cancer Therapeutics market size from 2024 to 2030? shouQi

What was the global market size of Kidney Cancer Therapeutics in 2030? shouQi

Related Reports

Kidney Cancer Therapeutics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Kidney Cancer Therapeutics was estimated to be worth US$ 452 million in 2024 and is forecast to a readjusted size of US$ 585 million by 2031 with a CAGR of 3.8% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 97
USD 3950.00
(Single User License)
Global Kidney Cancer Therapeutics Market Research Report 2025
The global market for Kidney Cancer Therapeutics was valued at US$ 452 million in the year 2024 and is projected to reach a revised size of US$ 585 million by 2031, growing at a CAGR of 3.8% during the forecast period.
Published Date: 2025-01-13
Pages: 78
USD 2900.00
(Single User License)
Global Kidney Cancer Therapeutics Market Research Report 2024
Kidney cancer is cancer that begins in the kidneys. Your kidneys are two bean-shaped organs, each about the size of your fist. They're located behind your abdominal organs, with one kidney on each side of your spine. In adults, renal cell carcinoma is the most common type of kidney cancer.
Published Date: 2024-01-17
Pages: 87
USD 2900.00
(Single User License)

Kidney Cancer Therapeutics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Kidney Cancer Therapeutics was estimated to be worth US$ 452 million in 2024 and is forecast to a readjusted size of US$ 585 million by 2031 with a CAGR of 3.8% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 97
USD 3950.00 (Single User License)
Global Kidney Cancer Therapeutics Market Research Report 2025
The global market for Kidney Cancer Therapeutics was valued at US$ 452 million in the year 2024 and is projected to reach a revised size of US$ 585 million by 2031, growing at a CAGR of 3.8% during the forecast period.
Published: 2025-01-13
Pages: 78
USD 2900.00 (Single User License)
Global Kidney Cancer Therapeutics Market Research Report 2024
Kidney cancer is cancer that begins in the kidneys. Your kidneys are two bean-shaped organs, each about the size of your fist. They're located behind your abdominal organs, with one kidney on each side of your spine. In adults, renal cell carcinoma is the most common type of kidney cancer.
Published: 2024-01-17
Pages: 87
USD 2900.00 (Single User License)